Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial.
Iglesias J.F., Muller O., Heg D., Roffi M., Kurz D.J., Moarof I., Weilenmann D., Kaiser C., Tapponnier M., Stortecky S. et al., 2019/10/05. Lancet, 394 (10205) pp. 1243-1253. Peer-reviewed.
ici le détail